Comparative Pharmacology
Head-to-head clinical analysis: M V I 12 ADULT versus MVC PLUS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I 12 ADULT versus MVC PLUS.
M.V.I.-12 ADULT vs MVC PLUS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
M.V.I.-12 Adult is a multivitamin combination that supplies essential vitamins (A, D, E, C, B1, B2, B3, B5, B6, B12, folic acid, biotin) to maintain normal metabolic functions, act as cofactors in enzymatic reactions, and support cellular respiration, antioxidant defense, and erythropoiesis.
MVC PLUS is a fixed-dose combination of maraviroc, a CCR5 co-receptor antagonist, and lamivudine, a nucleoside reverse transcriptase inhibitor. Maraviroc binds to CCR5 on CD4+ T cells blocking HIV-1 entry; lamivudine inhibits HIV reverse transcriptase via competitive inhibition and chain termination.
10 mL (one vial) added to 500 mL of IV fluid, infused over 8-24 hours once daily.
10 mg orally once daily.
None Documented
None Documented
Variable by component: e.g., thiamine 9-18 days (tissue stores), vitamin C 10-20 days (depletion), vitamin A 50-100 days (liver stores). Clinical context: half-lives reflect slow depletion; daily dosing maintains plasma levels.
Terminal elimination half-life: 12-18 hours (mean 14 hours). Clinically, this supports twice-daily dosing with steady-state achieved in ~3 days.
Renal: water-soluble vitamins (B-complex, C) excreted in urine; fat-soluble vitamins (A, D, E, K) undergo biliary/fecal excretion. Specific percentages vary per component; e.g., vitamin C ~50% renal, thiamine ~30-70% renal as metabolites.
Renal: ~70% unchanged; Fecal: ~25%; Biliary: <5%
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement